arginine vasopressin has been researched along with Amyotrophic Lateral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González de Aguilar, JL; Gordon, JW; Kienlen-Campard, P; Loeffler, JP; Lutz-Bucher, B; René, F | 1 |
| Dobrov, SA; Golovkin, VI; Iampol'skaia, LI; Korovin, KF | 1 |
2 other study(ies) available for arginine vasopressin and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
A mouse model of familial amyotrophic lateral sclerosis expressing a mutant superoxide dismutase 1 shows evidence of disordered transport in the vasopressin hypothalamo-neurohypophysial axis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Arginine Vasopressin; Axonal Transport; Axons; Body Water; Cytoplasmic Granules; Disease Models, Animal; Female; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Transgenic; Mutation, Missense; Neurosecretion; Pituitary Gland; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1 | 1999 |
[Neuroendocrine aspects of the pathogenesis and treatment of disseminated sclerosis and lateral amyotrophic sclerosis].
Topics: Adult; Amyotrophic Lateral Sclerosis; Arginine Vasopressin; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Prognosis; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1990 |